Skip to main content

Ascent Industries Reports Second Quarter 2025 Results

Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions, is reporting its results for the second quarter ended June 30, 2025.

Second Quarter 2025 Summary1

(in millions, except per share and margin)

Q2 2025

Q2 2024

Change

Net Sales

$18.7

21.5

(13.0)%

Gross Profit

$4.9

$2.8

73.0%

Gross Profit Margin

26.1%

13.1%

1,298bps

Net Loss

$(2.4)

$(1.5)

60.0%

Diluted Loss per Share

$(0.25)

$(0.14)

78.6%

Adjusted EBITDA

$(0.3)

$(0.3)

-$52K

Adjusted EBITDA Margin

(1.8)%

(1.3)%

-50bps

____________________

1On April 4, 2025, the Company closed on a transaction to sell substantially all of the assets of Bristol Metals, LLC (“BRISMET”). On June 30, 2025, the Company closed on a transaction to sell substantially all of the assets of American Stainless Tubing, Inc ("ASTI"). As a result, financial results from BRISMET and ASTI have been categorized into discontinued operations.

Management Commentary

“In Q2 2025, we delivered on our portfolio-optimization commitments—completing the sale of BRISMET in April and ASTI in June—to fully transform Ascent into a pure-play specialty chemicals company,” said Bryan Kitchen, CEO of Ascent Industries.

“Even amid muted end-market demand and navigating two divestitures, our team delivered $4.9 million in gross profit from continuing operations in Q2 2025, lifting gross margin to 26.1%—up 1,298 basis points versus 13.1% in Q2 2024 and up 888 basis points versus 17% in Q1 2025— improvements reflective of our relentless focus on cost management, strategic sourcing, and ongoing product-line optimization."

"We are energized by a growing pipeline of high-quality growth opportunities and remain committed to driving durable value for our shareholders. Underscoring our confidence and commitment, we repurchased 644,171 shares—about 6% of our outstanding stock—in Q2 2025, returning cash directly to shareholders.”

Second Quarter 2025 Financial Results

Net sales from continuing operations were $18.7 million compared to $21.5 million in the second quarter of 2024. The decline was a result of lower volume partially offset by increased average selling prices.

Gross profit from continuing operations increased 73.0% to $4.9 million, or 26.1% of net sales, compared to $2.8 million, or 13.1% of net sales, in the second quarter of 2024. The increase was primarily driven by continued cost management, improved strategic sourcing, and continued product line optimization.

Net loss from continuing operations increased to ($2.4) million, or ($0.25) diluted loss per share compared to a net loss from continuing operations of ($1.5) million, or ($0.14) diluted loss per share, in the second quarter of 2024. Excluding the one-time asset impairment charge in the quarter, net loss from continuing operations decreased to ($0.8) million.

Adjusted EBITDA remained flat to prior year at ($0.3) million in the second quarter of 2025, with adjusted EBITDA margin decreasing to (1.8)% compared to (1.3)% in the prior year period. The decrease was primarily driven by the aforementioned decline in sales in the quarter.

On April 4, 2025, the Company closed on the sale of substantially all of the assets of Bristol Metals, LLC. ("BRISMET") for a transaction price of $45 million in cash, subject to working capital and other closing adjustments. On June 30, 2025, the Company closed on a transaction to sell substantially all of the assets of American Stainless Tubing, Inc ("ASTI") for a transaction price of $16 million in cash, subject to working capital and other closing adjustments. As a result of these transactions, financial results from BRISMET and ASTI have been categorized into discontinued operations and the Company no longer has any operating tubular assets.

Liquidity

As of June 30, 2025, the Company had $60.5 million in cash and cash equivalents, no debt outstanding under its revolving credit facilities and had $13.4 million in availability under its revolving credit facility.

For the quarter ended June 30, 2025, the Company repurchased 644,171 shares at an average cost of $12.15 per share for approximately $7.8 million.

Conference Call

Ascent will hold a conference call today at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2025.

Ascent management will host the conference call, followed by a question-and-answer period.

Date: Wednesday, August 6, 2025

Time: 5:00 p.m. Eastern time

Webcast Registration Link: Here

Toll-free dial-in number: 800-715-9871

International dial-in number: 646-307-1963

Conference ID: 2734329

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group, Inc. at 1-949-574-3860.

The conference call will also be broadcast live and available for replay via the webcast registration link above or here. The webcast will be archived for one year in the investor relations section of the Company’s website at www.ascentco.com.

About Ascent Industries Co.

Ascent Industries Co. (Nasdaq: ACNT) is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. For more information about Ascent, please visit its website at www.ascentco.com.

Forward-Looking Statements

This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.’s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.

Non-GAAP Financial Information

Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.

Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring & severance costs from net income (loss).

Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.

 

Ascent Industries Co.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share data)

 

 

(Unaudited)

 

 

 

June 30, 2025

 

December 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

60,479

 

 

$

16,098

 

Accounts receivable, net of allowance for credit losses of $1,067 and $202, respectively

 

12,345

 

 

 

12,232

 

Advances and other receivables

 

5,352

 

 

 

52

 

Inventories

 

6,666

 

 

 

5,727

 

Prepaid expenses and other current assets

 

2,069

 

 

 

1,122

 

Current assets of discontinued operations

 

 

 

 

47,841

 

Total current assets

 

86,911

 

 

 

83,072

 

Property, plant and equipment, net

 

16,242

 

 

 

17,589

 

Right-of-use assets, operating leases, net

 

15,401

 

 

 

28,140

 

Intangible assets, net

 

3,139

 

 

 

3,445

 

Deferred charges, net

 

376

 

 

 

309

 

Other non-current assets, net

 

511

 

 

 

512

 

Long-term assets of discontinued operations

 

 

 

 

14,183

 

Total assets

$

122,580

 

 

$

147,250

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

5,197

 

 

$

6,836

 

Accrued expenses and other current liabilities

 

5,484

 

 

 

3,598

 

Current portion of note payable

 

1,084

 

 

 

369

 

Current portion of operating lease liabilities

 

1,016

 

 

 

1,495

 

Current portion of finance lease liabilities

 

301

 

 

 

293

 

Current liabilities of discontinued operations

 

 

 

 

9,756

 

Total current liabilities

 

13,082

 

 

 

22,347

 

Long-term portion of operating lease liabilities

 

18,823

 

 

 

29,972

 

Long-term portion of finance lease liabilities

 

862

 

 

 

1,015

 

Deferred income taxes

 

49

 

 

 

320

 

Other long-term liabilities

 

48

 

 

 

51

 

Total non-current liabilities

 

19,782

 

 

 

31,358

 

Total liabilities

$

32,864

 

 

$

53,705

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

Common stock, par value $1 per share; 24,000,000 shares authorized; 9,430,183 and 10,072,590 shares outstanding as of June 30, 2025 and December 31, 2024 , respectively

$

11,085

 

 

$

11,085

 

Capital in excess of par value

 

47,375

 

 

 

47,339

 

Retained earnings

 

48,912

 

 

 

44,919

 

 

 

107,372

 

 

 

103,343

 

Less: cost of common stock in treasury - 1,654,920 and 1,012,513 shares, respectively

 

(17,656

)

 

 

(9,798

)

Total shareholders' equity

 

89,716

 

 

 

93,545

 

Total liabilities and shareholders' equity

$

122,580

 

 

$

147,250

 

 

Note: The condensed consolidated balance sheets at December 31, 2024 have been derived from the audited consolidated financial statements at that date.

 

Ascent Industries Co.

Condensed Consolidated Statements of Income (Loss) (Unaudited)

($ in thousands, except per share data)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

2024

 

 

 

2023

 

Net sales

$

18,652

 

 

$

21,468

 

 

$

36,486

 

 

$

41,764

 

Cost of sales

 

13,786

 

 

 

18,655

 

 

 

28,553

 

 

 

37,565

 

Gross profit

 

4,866

 

 

 

2,813

 

 

 

7,933

 

 

 

4,199

 

Selling, general and administrative

 

6,444

 

 

 

4,604

 

 

 

11,315

 

 

 

10,484

 

Acquisition costs and other

 

31

 

 

 

52

 

 

 

268

 

 

 

52

 

Asset impairments

 

1,622

 

 

 

 

 

 

1,622

 

 

 

 

Gain on lease modification

 

(544

)

 

 

 

 

 

(544

)

 

 

 

Operating loss from continuing operations

 

(2,687

)

 

 

(1,843

)

 

 

(4,728

)

 

 

(6,337

)

Other expense (income)

 

 

 

 

 

 

 

Interest expense, net

 

(15

)

 

 

72

 

 

 

99

 

 

 

199

 

Other, net

 

(136

)

 

 

(93

)

 

 

(285

)

 

 

(212

)

Loss from continuing operations before income taxes

 

(2,536

)

 

 

(1,822

)

 

 

(4,542

)

 

 

(6,324

)

Income tax benefit

 

(89

)

 

 

(372

)

 

 

(89

)

 

 

(1,393

)

Loss from continuing operations

 

(2,447

)

 

 

(1,450

)

 

 

(4,453

)

 

 

(4,931

)

Income (loss) from discontinued operations, net of tax

 

8,733

 

 

 

524

 

 

 

8,446

 

 

 

(1,488

)

Net income (loss)

$

6,286

 

 

$

(926

)

 

$

3,993

 

 

$

(6,419

)

 

 

 

 

 

 

 

 

Net loss per common share from continuing operations:

 

 

 

 

 

 

 

Basic

$

(0.25

)

 

$

(0.14

)

 

$

(0.45

)

 

$

(0.49

)

Diluted

$

(0.25

)

 

$

(0.14

)

 

$

(0.45

)

 

$

(0.49

)

 

 

 

 

 

 

 

 

Net income (loss) per common share from discontinued operations:

 

 

 

 

 

 

 

Basic

$

0.90

 

 

$

0.05

 

 

$

0.85

 

 

$

(0.15

)

Diluted

$

0.90

 

 

$

0.05

 

 

$

0.85

 

 

$

(0.15

)

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

$

0.65

 

 

$

(0.09

)

 

$

0.40

 

 

$

(0.63

)

Diluted

$

0.65

 

 

$

(0.09

)

 

$

0.40

 

 

$

(0.63

)

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic

 

9,751

 

 

 

10,126

 

 

 

9,913

 

 

 

10,110

 

Diluted

 

9,751

 

 

 

10,126

 

 

 

9,913

 

 

 

10,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA1

$

(335

)

 

$

(283

)

 

$

(802

)

 

$

(3,430

)

1The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, retention costs and restructuring & severance costs from net income (loss). For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.

 

Ascent Industries Co.

Consolidated Statements of Cash Flows (Unaudited)

($ in thousands)

 

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

Operating activities

 

 

 

Net income (loss)

$

3,993

 

 

$

(6,419

)

Income (loss) from discontinued operations, net of tax

 

8,446

 

 

 

(1,488

)

Net loss from continuing operations

 

(4,453

)

 

 

(4,931

)

Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:

 

 

 

Depreciation expense

 

1,870

 

 

 

1,961

 

Amortization expense

 

306

 

 

 

347

 

Amortization of debt issuance costs

 

179

 

 

 

50

 

Asset impairments

 

1,622

 

 

 

 

Deferred income taxes

 

(90

)

 

 

(1,393

)

(Reduction of) provision for losses on accounts receivable

 

(506

)

 

 

217

 

Non-cash lease expense

 

(1

)

 

 

61

 

Stock-based compensation expense

 

222

 

 

 

360

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable and advances

 

(4,908

)

 

 

1,013

 

Inventories

 

(939

)

 

 

2,338

 

Other assets and liabilities

 

(1,937

)

 

 

(815

)

Accounts payable

 

(1,712

)

 

 

(89

)

Accrued expenses

 

1,387

 

 

 

1,003

 

Accrued income taxes

 

19

 

 

 

630

 

Net cash (used in) provided by operating activities - continuing operations

 

(8,941

)

 

 

752

 

Net cash provided by operating activities - discontinued operations

 

6,845

 

 

 

1,678

 

Net cash (used in) provided by operating activities

 

(2,096

)

 

 

2,430

 

Investing activities

 

 

 

Purchases of property, plant and equipment

 

(466

)

 

 

(458

)

Net cash used in investing activities - continuing operations

 

(466

)

 

 

(458

)

Net cash provided by (used in) investing activities - discontinued operations

 

54,425

 

 

 

(312

)

Net cash provided by (used in) investing activities

 

53,959

 

 

 

(770

)

Financing activities

 

 

 

Borrowings from credit facilities

 

89,670

 

 

 

107,700

 

Proceeds from note payable

 

1,085

 

 

 

914

 

Payments on credit facilities

 

(89,670

)

 

 

(107,700

)

Payments on note payable

 

(370

)

 

 

(359

)

Principal payments on finance lease obligations

 

(144

)

 

 

(148

)

Repurchase of common stock

 

(8,044

)

 

 

(320

)

Net cash (used in) provided by financing activities - continuing operations

 

(7,473

)

 

 

87

 

Net cash used in financing activities - discontinued operations

 

(19

)

 

 

(3

)

Net cash (used in) provided by financing activities

 

(7,492

)

 

 

84

 

Decrease in cash and cash equivalents

 

44,371

 

 

 

1,744

 

Less: Cash and cash equivalents of discontinued operations

 

 

 

 

10

 

Cash and cash equivalents, beginning of period

 

16,108

 

 

 

1,841

 

Cash and cash equivalents, end of period

$

60,479

 

 

$

3,595

 

Ascent Industries Co.

Non-GAAP Financial Measures Reconciliation

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)

($ in thousands)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

($ in thousands)

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Consolidated

 

 

 

 

 

 

 

Net loss from continuing operations

$

(2,447

)

 

$

(1,450

)

 

$

(4,453

)

 

$

(4,931

)

Adjustments:

 

 

 

 

 

 

 

Interest expense, net

 

(15

)

 

 

72

 

 

 

99

 

 

 

199

 

Income taxes

 

(89

)

 

 

(372

)

 

 

(89

)

 

 

(1,393

)

Depreciation

 

893

 

 

 

985

 

 

 

1,870

 

 

 

1,961

 

Amortization

 

153

 

 

 

179

 

 

 

306

 

 

 

348

 

EBITDA

 

(1,505

)

 

 

(586

)

 

 

(2,267

)

 

 

(3,816

)

Acquisition costs and other

 

31

 

 

 

52

 

 

 

268

 

 

 

52

 

Asset impairments

 

1,622

 

 

 

 

 

 

1,622

 

 

 

 

Gain on lease modification

 

(544

)

 

 

 

 

 

(544

)

 

 

 

Stock-based compensation

 

86

 

 

 

44

 

 

 

120

 

 

 

93

 

Non-cash lease expense

 

(25

)

 

 

30

 

 

 

(1

)

 

 

61

 

Retention expense

 

 

 

 

 

 

 

 

 

 

3

 

Restructuring and severance costs

 

 

 

 

177

 

 

 

 

 

 

177

 

Adjusted EBITDA

$

(335

)

 

$

(283

)

 

$

(802

)

 

$

(3,430

)

% sales

 

(1.8

)%

 

 

(1.3

)%

 

 

(2.2

)%

 

 

(8.2

)%

 

 

 

 

 

 

 

 

Specialty Chemicals

 

 

 

 

 

 

 

Net income (loss)

$

1,499

 

 

$

409

 

 

$

2,237

 

 

$

(1,049

)

Adjustments:

 

 

 

 

 

 

 

Interest expense, net

 

15

 

 

 

20

 

 

 

32

 

 

 

39

 

Depreciation

 

878

 

 

 

964

 

 

 

1,840

 

 

 

1,918

 

Amortization

 

153

 

 

 

179

 

 

 

306

 

 

 

348

 

EBITDA

 

2,545

 

 

 

1,572

 

 

 

4,415

 

 

 

1,256

 

Acquisition costs and other

 

 

 

 

 

 

 

92

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

7

 

Non-cash lease expense

 

(5

)

 

 

19

 

 

 

3

 

 

 

38

 

Restructuring and severance costs

 

 

 

 

109

 

 

 

 

 

 

109

 

Specialty Chemicals Adjusted EBITDA

$

2,540

 

 

$

1,700

 

 

$

4,510

 

 

$

1,410

 

% segment sales

 

13.6

%

 

 

7.9

%

 

 

12.4

%

 

 

3.4

%

 

Contacts

Company Contact

Ryan Kavalauskas

Chief Financial Officer

1-630-884-9181

Investor Relations

Ralf Esper

Gateway Group, Inc.

1-949-574-3860

ACNT@gateway-grp.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.